Alliance Pharma (LON:APH) Stock Crosses Below 200 Day Moving Average of $57.81

Alliance Pharma plc (LON:APH)’s share price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 57.81 ($0.73) and traded as low as GBX 46.60 ($0.59). Alliance Pharma shares last traded at GBX 47 ($0.59), with a volume of 754,046 shares.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. Numis Securities reissued a “buy” rating and issued a GBX 105 ($1.33) target price on shares of Alliance Pharma in a report on Thursday, May 25th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 105 ($1.33) price target on shares of Alliance Pharma in a report on Thursday, May 25th.

Alliance Pharma Stock Performance

The stock has a market capitalization of £253.87 million, a P/E ratio of 3,450.00, a P/E/G ratio of 1.04 and a beta of 0.52. The company has a quick ratio of 1.42, a current ratio of 2.24 and a debt-to-equity ratio of 47.83. The business has a fifty day moving average price of GBX 47.95 and a 200-day moving average price of GBX 57.81.

Insider Activity

In other news, insider Andrew Franklin acquired 50,988 shares of Alliance Pharma stock in a transaction that occurred on Tuesday, July 18th. The stock was bought at an average price of GBX 49 ($0.62) per share, for a total transaction of £24,984.12 ($31,553.57). In other news, insider Andrew Franklin acquired 50,988 shares of Alliance Pharma stock in a transaction that occurred on Tuesday, July 18th. The stock was bought at an average price of GBX 49 ($0.62) per share, for a total transaction of £24,984.12 ($31,553.57). Also, insider Jo Le Couilliard acquired 40,957 shares of Alliance Pharma stock in a transaction that occurred on Thursday, July 20th. The shares were purchased at an average price of GBX 49 ($0.62) per share, with a total value of £20,068.93 ($25,345.96). Corporate insiders own 9.79% of the company’s stock.

About Alliance Pharma

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.